1. V. I. Konenkov, Yu. I. Borodin, and M. S. Lyubarskii, Lymphology [in Russian] Novosibirsk (2012) pp. 9–15
2. A. P. Lykov, A. V. Kabakov, O. V. Poveshchenko, N. A. Bondarenko, A. F. Poveshchenko, O. V. Kazakov, Y. V. Nikonoriva, and V. I. Konenkov, Efficiency of therapy by the cellular product of the sharp myocardial infarction at rats of the Wistar line according to bioelectric activity of the myocardium. Mezhdunar. Zh. Priklad. Fundament. Issled., No. 8–4, 78–84 (2014).
3. A. F. Poveschenko, L. A. Shundrin, P. A. Avrorov, A. O. Solovieva, T. V. Miller, K. E. Zubareva, T. V. Voloshina, O. V. Poveschenko, and V. I. Konenkov, Molecular technology research of bone marrow cells migration. Sovrem. Naukoemkie Tekhnologii, No. 11, 22–30 (2015).
4. A. A. Terentiev, G. V. Poryadin, J. M. Salmasi, I. A. Alexandrova, A. K. Tagirova, N. T. Moldogazieva, and A. N. Kazimirsky, Increase of CD95+−lymphocytes apoptoses under influence of synthetic peptide from the human alpha-fetoprotein (AFP14–20). Sovrem. Naukoemkie Tekhnologii, No. 10, 66–68 (2005).
5. T. Kh. Fatkhudinov, G. B. Bol’shakova, D. V. Goldshtein, and G. T. Sukhikh, Mechanisms of Therapeutic Activity of Multi-potent Cells in Heart Diseases. Bull. Exp. Biol. Med., 156, No. 4, 535–543 (2014).